Dual action inhibitors containing a pyridazinodiazepine or pyraz

Details Dual action inhibitors containing a pyridazinodiazepine or pyraz Dual action inhibitors containing a pyridazinodiazepine or pyraz

1995-04-17

1998-03-03

Ford, John M.

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C07D48704

Patent

active

057236020

ABSTRACT:
Compounds of the formula ##STR1## wherein X.sub.1 is ##STR2## are disclosed. These compounds possess inhibitory activity against angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) and are thus useful as cardiovascular agents.

REFERENCES:
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4192945 (1980-03-01), Ondetti
patent: 4339600 (1982-07-01), Ondetti et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4409146 (1983-10-01), Thorsett
patent: 4410520 (1983-10-01), Watthey
patent: 4415496 (1983-11-01), Harris et al.
patent: 4460579 (1984-07-01), Karanewsky
patent: 4465679 (1984-08-01), Huang et al.
patent: 4470988 (1984-09-01), Watthey
patent: 4473575 (1984-09-01), Watthey
patent: 4477464 (1984-10-01), Slade et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4537885 (1985-08-01), Watthey
patent: 4539150 (1985-09-01), Katakmi et al.
patent: 4548932 (1985-10-01), Sugihara et al.
patent: 4575503 (1986-03-01), Watthey
patent: 4584294 (1986-04-01), Ruyle
patent: 4587050 (1986-05-01), Harris et al.
patent: 4587238 (1986-05-01), Harris et al.
patent: 4594341 (1986-06-01), Cheung et al.
patent: 4617301 (1986-10-01), Patchett et al.
patent: 4629787 (1986-12-01), Harris et al.
patent: 4680392 (1987-07-01), Harris et al.
patent: 4699905 (1987-10-01), Yangisawa et al.
patent: 4711884 (1987-12-01), Karanewsky
patent: 4734410 (1988-03-01), Yanagisawa et al.
patent: 4749688 (1988-06-01), Haslanger
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4873235 (1989-10-01), Parsons et al.
patent: 4963539 (1990-10-01), Delaney
patent: 4973585 (1990-11-01), Flynn et al.
patent: 5075302 (1991-12-01), Neustadt
patent: 5098934 (1992-03-01), Vevert et al.
patent: 5190974 (1993-03-01), Clemence et al.
patent: 5208236 (1993-05-01), Neustadt
patent: 5223516 (1993-06-01), Delaney
patent: 5225401 (1993-07-01), Seymour
patent: 5232920 (1993-08-01), Neustadt
patent: 5238924 (1993-08-01), Smith
patent: 5262436 (1993-11-01), Haslanger et al.
patent: 5362727 (1994-11-01), Robl
patent: 5366973 (1994-11-01), Flynn et al.
patent: 5486513 (1996-01-01), Warshawsky et al.
Karanewsky et al, Chemical Abstract 122:81350 for CA 2096460 (Nov. 19, 1993).
Flynn et al, Chem. Abstract 121:83391 for WO 93/23403 (Nov. 25, 1993).
Boyer, T.D. "Cirrhosis of the Liver and Its Major Sequelae", in: Wyngaardon, J.E., et al., Gill Textbook of Medicine, vol. 1 (Philadelphia, Saunders Co., 1992), pp. 786-789.
Watthey et al., J. Med. Chem., 28, pp. 1511-1516 (1985).
Slade et al., J. Med. Chem., 28, pp. 1517-1521 (1985).
Thorsett et al., J. Med. Chem., 29, pp. 251-260 (1986).
Yanagisawa et al., J. Med. Chem., 30, pp. 1984-1991 (1987).
Yanagisawa et al., J. Med. Chem., 31, pp. 422-428 (1988).
Parsons et al., Biochem and Biophysical Research Comm. 117, pp. 108-113 (1993).
Atwood et al., FEBS Letters, vol. 165, pp. 201-206 (1984).
Natoff et al., Drugs Of the Future, vol. 12, pp. 475-483 (1987).
Itoh et al., Chem. Pharm. Bull., vol. 34, pp. 1128-1147 and 2078-2089.
Flynn, Tetrahedron Letters, vol. 31, pp. 815-818 (1990).
Thorsett, Actual Chim. Ther., vol. 13, pp. 257-268 (1986).
Atwood et al., J. Chem. Soc. Perkin Trans I (1986) pp. 1011-1019.
Robl, Tetrahedron Letters, vol. 35, pp. 393-396 and 1393-1396, (1994).
Delaney et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1783-1788 (1994).
Robl et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1789-1794 (1994).
Robl et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 2055-2060 (1994).
Das et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 2193-2198 (1994).
Bolos et al., J. Org. Chem., 57, 3535-3539 (1992).
Bolos et al., Tetrahedron, vol. 48, pp. 9567-9576 (1992).
Adams et al., Synthetic Communications, vol. 18, 2225-2231 (1988).
Chackalamannil et al., Bioorganic & Medicinal Chemistry Letters, vol. 2, pp. 1003-1006 (1992).
Flynn et al., J. Med. Chem., 36, pp. 2420-2423 (1993).
Robl et al., J. Am. Chem. Soc., 116, pp. 2348-2355 (1994).
Robl et al., Biiorganic & Medicinal Chem. Letters, vol. 4, pp. 1795-1800, 1994.
Dussaule et al., Jour. of Clinical Endocrinology and Metabolism, vol. 72, pp. 653-659, 1991.
Laffi et al., Gastroenterology, vol. 96, pp. 167-177, 1989.
Fyhrquist et al., The Lancet, Dec. 21/28, 1985, p. 1439.
Fernandez-Cruz, The Lancet, Dec. 21/28, 1985, pp. 1439-1440.
Naming and Indexing of Chemical Substances for Chemical Abstracts, 1987 Index Guide, Section 203.

Affiliated with

Also associated with

Rating

Dual action inhibitors containing a pyridazinodiazepine or pyraz does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dual action inhibitors containing a pyridazinodiazepine or pyraz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual action inhibitors containing a pyridazinodiazepine or pyraz will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2249007